Why this exists

The Comprehensive Addiction and Recovery Act of 2016 created the Pain Management Best Practices Inter-Agency Task Force, whose recommendations included safer opioid stewardship through risk assessment based on patients’ medical, social and family history to ensure safe and appropriate prescribing. That is a specific instruction and it is a good one. It is also not what usually happens, because doing it takes time and the alternative — reading a dose number — takes none.

Note what the recommendation is for: appropriate prescribing. Not exclusion. A risk assessment that only ever produces reasons to withhold treatment is not implementing this recommendation; it is using its vocabulary.

How it works

• Medical history — the pain diagnosis, comorbidity, prior therapy tried and its result, and the non-opioid load, including NSAID and acetaminophen exposure that the federal material specifically flags for renal, gastric, cardiac and hepatic risk.
• Behavioral health — via validated instruments rather than impression.
• Social circumstances — via social determinants verification, because they determine whether an intervention can work at all.
• Family history, as the Task Force recommendation specifies.
• Co-prescriptions, including non-scheduled medication that contributes to sedation.

The output is a picture with actions attached: what support this person needs, what needs clinical follow-up, what should be avoided. Not a score.

It is not a risk score that decides who gets treatment. The purpose is to determine what support a patient needs, not whether they deserve care.

It is not a permanent label. Circumstances change, and an assessment that is never revisited becomes a stereotype attached to a person.

It is not shared with an agency at the individual level, and it is not a case-building instrument.

It is not used to justify a taper. CDC’s 2022 guideline is explicit that patients should not be dismissed on the basis of monitoring or toxicology information, and the same logic applies here.